Dr. med. Christian Wilms

No current affiliations available for this person. The person is no longer active at the university.

Publications

563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020) In: (eds.), . (no publisher available). Type of Publication: Research article in edited proceedings (conference)
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020) In: Cancers, 12(6) Type of Publication: Research article (journal)
Repeated radioembolization in advanced liver Cancer. Masthoff M, Schindler P, Harders F, Heindel W, Wilms C, Schmidt HH, Pascher A, Stegger L, Rahbar K, Wildgruber M, Köhler M. "Repeated radioembolization in advanced liver cancer". ):1055, published https://dx.doi.org/10.21037/atm-20-2658 (2020) In: Ann Transl. Med 2020, 8 (17), 2020(8) Type of Publication: Research article (journal)
Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Wilms C, Hüsing-Kabar A, Görlich D, Kabar I, Schmidt HHJ (2017) In: PloS one, 12(4) Type of Publication: Research article (journal)